Patient Square Capital as of Sept. 30, 2024
Portfolio Holdings for Patient Square Capital
Patient Square Capital holds 11 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Roivant Sciences SHS (ROIV) | 52.4 | $141M | 12M | 11.54 | |
| Liquidia Corporation Com New (LQDA) | 26.7 | $72M | 7.2M | 10.00 | |
| Cullinan Oncology (CGEM) | 5.1 | $14M | 825k | 16.74 | |
| Insmed Com Par $.01 (INSM) | 4.7 | $13M | 172k | 73.00 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 4.0 | $11M | 1.4M | 7.99 | |
| Nurix Therapeutics (NRIX) | 2.7 | $7.3M | 326k | 22.47 | |
| Pharvaris N V (PHVS) | 1.7 | $4.5M | 242k | 18.52 | |
| Intellia Therapeutics (NTLA) | 1.0 | $2.6M | 129k | 20.55 | |
| Enliven Therapeutics (ELVN) | 0.9 | $2.3M | 91k | 25.54 | |
| Ocular Therapeutix (OCUL) | 0.8 | $2.0M | 236k | 8.70 | |
| Astria Therapeutics (ATXS) | 0.2 | $434k | 39k | 11.01 |
